AutoInjector

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1973-2018
051019732018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
BACKGROUND Secukinumab is a fully human anti-interleukin-17A monoclonal antibody. OBJECTIVE Determine the efficacy, safety and… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
2015
2015
OBJECTIVES To evaluate factors influencing injection patterns and patient evaluations of an autoinjector device in biologic-naïve… (More)
Is this relevant?
2013
2013
BACKGROUND Training programs performed by allergists have increased the ability of patients' recognition and management of… (More)
Is this relevant?
2012
2012
BACKGROUND Although adrenaline is recommended as first line treatment for anaphylaxis, it is often not utilized. There has been a… (More)
Is this relevant?
2011
2011
The majority of physicians do not know how to use epinephrine autoinjectors. This displays that current education of physicians… (More)
  • figure 1
  • table 2
  • table 3
Is this relevant?
2010
2010
OBJECTIVE A disposable autoinjector was developed for subcutaneous (SC) self-injection by patients with chronic diseases. To… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2008
2008
BACKGROUND Peanut allergy accounts for most severe food-related allergic reactions, and accidental exposures are frequent… (More)
  • table 1
  • figure 1
Is this relevant?
2004
2004
The treatment of organophosphate-induced poisoning is based mainly on atropine and an oxime. Prompt anticonvulsive intervention… (More)
  • figure 2
  • figure 1
  • figure 3
  • table 1
Is this relevant?
2000
2000
BACKGROUND EpiPen and EpiPen Jr autoinjectors are often recommended for prehospital treatment of anaphylaxis. When these units… (More)
Is this relevant?
1995
1995
A newly developed autoinjector (Astra Tech, Sweden) containing 500 mg HI-6 and 2 mg atropine sulphate was tested in anaesthetized… (More)
Is this relevant?